AbbVie proposes $46bn bid for Shire; fifth offer of $53.3bn accepted; deal terminated in response to new US tax code
- Specialty Pharmaceuticals
- Full Acquisition
- Includes Contract
- Payment Includes Cash
- Payment Includes Stock
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.